Efficacy of rasagiline monotherapy for early Parkinson disease: A systematic review and meta-analysis of randomized controlled trials
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Psychopharmacology"
DOI: 10.1177/02698811221093795
Abstract: Background: Rasagiline monotherapy is approved in early Parkinson’s disease (PD) for motor benefit. However, the efficacy and optimal rasagiline dosage in improving Unified Parkinson’s Disease Rating Scale (UPDRS) subscale scores between Japanese and Caucasian individuals… read more here.
Keywords: rasagiline monotherapy; parkinson disease; rasagiline;